NATIONAL
INSTITUTES OF HEALTH, DEPARTMENT OF HEALTH AND HUMAN SERVICES
AUTHORIZATION:
Public
Health Service Act, Section 301, Public Law 78-410, 42 U.S.C. 241,
as amended; Small Business Research and Development Enhancement
Act of 1992, Public Law 102-564.
To
conduct a broad-scale effort in biometry and risk estimation. Most
of the research conducted by the National Institute of Environmental
Health Sciences (NIEHS) in statistics, biomathematics, epidemiology,
and risk estimation is directed towards estimating probable health
risks of cancer, reproductive and neurological effects, and other
adverse effects from human exposures to various environmental hazards.
The major emphases are placed upon refining existing methods for
estimating human risk from data derived from studying laboratory
animals and on examining the quantitative issues involved in designing
short-term tests and interpreting the data from these tests. NIEHS
grants in support of epidemiology gather information about respiratory
disease and deaths due to air pollution, and determine better ways
to estimate the degree of human exposure to pollutants in drinking
water. Small Business Innovation Research (SBIR) program: To expand
and improve the SBIR program; to increase private sector commercialization
of innovations derived from Federal research and development; to
increase small business participation in Federal research and development;
and to foster and encourage participation of socially and economically
disadvantaged small business concerns and women-owned small business
concerns in technological Innovation. Small Business Technology
Transfer (STTR) program: To stimulate and foster scientific and
technological innovation through cooperative research and development
carried out between small business concerns and research institutions;
to foster technology transfer between small business concerns and
research institutions; to increase private sector commercialization
of innovations derived from Federal research and development; and
to foster and encourage participation of socially and economically
disadvantaged small business concerns and women-owned small business
concerns in technological innovation. Environmental Health Sciences
Education Program: To improve the understanding of environmental
health issues by students; and to expand career awareness in environmental
health issues by students; and to expand career awareness in environmental
health sciences research and services occupations by developing
educational materials for Grades K-12.
TYPES
OF ASSISTANCE:
Project Grants. Place Cursor Here for Definition
USES
AND USE RESTRICTIONS:
Research Grants: Research
Grants and Cooperative Agreements are intended to support the direct
costs of a project, in accordance with an approved budget, plus
an appropriate amount for indirect costs. Environmental health sciences
education grants are limited to $100,000 direct costs plus indirect
costs calculated at 8 percent of appropriate direct cost base and
they should promote the development of instructional material. SBIR
Phase I grants (of approximately 6-months' duration) are to establish
the technical merit and feasibility of a proposed research effort
that may lead to a commercial product or process. Phase II grants
are for the continuation of the research initiated in Phase I and
that are likely to result in commercial products or processes. Only
Phase I awardees are eligible to receive Phase II support. STTR
Phase I grants (normally of 1-year duration) are to determine the
scientific, technical, and commercial merit and feasibility of the
proposed cooperative effort that has potential for commercial application.
Phase II funding is based on results of research initiated in Phase
I and scientific and technical merit and commercial potential of
Phase II application. Independent Scientist Awards (Supersedes former
Research Career Development Award): These awards in amounts up to
$50,000 (plus fringe benefits, 8 percent indirect cost) are made
to institutions to provide stable salary support for the development
of newly independent scientists to enable them to expand their potential
to make significant contributions to their field of research. Supplementation
from nonfederal funds is allowed. Mentored Research Scientist Development
Awards (encompass the previous Mid-Career Development Awards and
the Minority School Faculty Development Awards): These awards are
in amounts up to $50,000 (plus fringe benefits, eight percent indirect
costs, and $10,000 for research support) and are made to institutions
to provide salary and research support for research scientists who
need an additional period of sponsored research as a way to gain
experience in a research area new to the candidate or in an area
that would demonstrably enhance the candidate's scientific career.
Supplementation from nonfederal funds is allowed. Mentored Clinical
Scientist Development Awards (encompass the previous Physician Scientist
Awards and Clinical Investigator Awards): Awards up to $50,000 (salary),
$10,000 to $20,000 for research support plus eight percent indirect
costs and fringe benefits, to provide for specialized study for
clinically trained professionals who are committed to a career in
research and have the potential to develop into independent investigators.
Supplementation from nonfederal funds is allowed. Academic Career
Awards (supersedes the Academic Award in Environmental/Occupational
Medicine): Up to $50,000 (salary), $10,000 to $20,000 for research
support, plus eight percent indirect costs and fringe benefits to
develop environmental/occupational medicine curriculum/faculty at
schools of medicine and osteopathy. Supplementation from nonfederal
funds is allowed.
ELIGIBILITY REQUIREMENTS:
Applicant Eligibility:
Research Grants, Cooperative Agreements, Science Education Grants,
SBIR Grants, Independent Scientist Awards, Mentored Research Scientist
Development Award, Mentored Clinical Scientist Development Award,
and the Academic Career Awards: A university, college, hospital,
State or local government, nonprofit research institution, or for-profit
organization may submit an application and receive a grant for support
of research by a named principal investigator. Candidates for Academic
Career Awards must have a doctoral degree and peer-reviewed, independent,
research support at the time the award is made. Candidates for Mentored
Clinical Scientist Development Awards must have a clinical degree
or its equivalent and must have initiated post graduate clinical
training. Candidates holding a Ph.D. degree are ineligible. Candidates
who have served as principal investigators on PHS-supported research
projects are ineligible. A candidate for Academic Career Awards
must have a clinical or research doctorate degree. Those eligible
for the Development Award must be able to devote at least 75 percent
effort. Those eligible for the Leadership Award must have an academic
appointment at a level sufficient to enable him/her to exert an
influence on the coordination of research, teaching, and clinical
practice in an emerging field and must be able to devote at least
25 percent effort. SBIR grants can be awarded only to domestic small
businesses (entities that are independently owned and operated for
profit, are not dominant in the field in which research is proposed,
and have no more than 500 employees). Primary employment (more than
one-half time) of the principal investigator must be with the small
business at the time of award and during the conduct of the proposed
project. In both Phase I and Phase II, the research must be performed
in the U.S. and its possessions. STTR grants can be awarded only
to domestic small business concerns (entities that are independently
owned and operated for profit, are not dominant in the field in
which research is proposed and have no more than 500 employees)
which "partner" with a research institution in cooperative research
and development. At least 40 percent of the project is to be performed
by the small business concern and at least 30 percent by the research
institution. In both Phase I and Phase II, the research must be
performed in the U.S. and its possessions. To be eligible for funding,
a grant application must be approved for scientific merit and program
relevance by a scientific review group and a national advisory council.
Beneficiary Eligibility:
Any nonprofit or for-profit organization, company, or institution
engaged in biomedical research.
Credentials/Documentation:
Research Grants, Science Education Grants, Cooperative Agreements,
Independent Scientist Awards, Mentored Research Scientist Development
Awards, Mentored Clinical Scientist Development Awards, and Academic
Career Awards: Applications must be signed by appropriate officials
of the submitting institution. Costs will be determined in accordance
with OMB Circular No. A-87 for State and local governments. For-profit
organizations' costs are determined in accordance with 48 CFR,
Subpart 31.2 of the Federal Acquisition Regulations. For other
grantees, costs will be determined by HHS Regulations 45 CFR,
Part 74, Subpart Q. For SBIR and STTR grants, applicant organization
(small business concern) must present in a research plan an idea
that has potential for commercialization and furnish evidence
that scientific competence, experimental methods, facilities,
equipment, and funds requested are appropriate to carry out the
plan. Grant forms PHS 6246-2 and PHS 6426-2 are used to apply
for SBIR Phase I and Phase II, respectively. Grant forms PHS 6246-3
and PHS 6246-4 are used to apply for STTR Phase I and Phase II,
respectively.
Pre-application
Coordination: Not applicable. This program is
excluded from coverage under E.O. 12372.
Application Procedure:
Research Grants, Science Education Grants, Cooperative Agreements,
SBIR Grants and Awards: Application forms and instructions for
their submission are available from the Division of Extramural
Outreach and Information Resources, National Institutes of Health,
6701 Rockledge Drive, MSC-7910, Bethesda, MD 20892. Small Business
Technology Transfer (STTR) program uses same procedure as SBIR
immediately above. The standard application forms, as furnished
by PHS and required by 45 CFR, Part 92, must be used for this
program by those applicants which are State and local units of
government. SBIR and STTR Grant Solicitations and SBIR Contract
Solicitation may be obtained electronically through the NIH's
"Small Business Funding Opportunities" home page at www.nih.gov/grants/funding/sbir.htm
on the World Wide Web. A limited number of hard copies of these
publications are produced. Subject to availability, they may be
obtained by contacting the NIH support services contractor: Telephone:
(301) 206-9385; fax: (301) 206-9722; e-mail: a2y@cu.nih.gov. The
Solicitations include submission procedures, review considerations,
and grant application or contract proposal forms. SBIR and STTR
grant applications should be submitted to the Center for Scientific
Review, 6701 Rockledge Drive, Room 1040 - MSC 7710, Bethesda,
MD 20892-7710.
Award Procedure:
Grants and Awards: Made on the basis of dual review of an investigator-prepared
application. The reviews are made by peer groups: the first by
a study section for scientific merit; the second by an advisory
council for program relevance. Final approval of these recommendations
and decisions concerning funding are made by the Director, NIEHS.
All accepted applications are evaluated for technical merit by
an appropriate scientific review group and by a national advisory
council. All accepted SBIR and STTR applications are evaluated
for scientific and technical merit by an appropriate scientific
peer review panel and by a national advisory council or board.
All applications receiving a priority score compete for available
SBIR/STTR set-aside funds on the basis of scientific and technical
merit and commercial potential of the proposed research, program
relevance, and program balance among the areas of research.
Deadlines:
Independent Scientist Awards, Mentored Research Scientist Development
Awards, Mentored Clinical Scientist Development Awards and the
Academic Career Awards: All new applications: February 1, June
1, and October 1. Supplemental applications and renewals applications:
March 1, July 1, and November 1. SBIR applications: April 15,
August 15, and December 15. STTR: December 1, only.
Range of Approval/Disapproval
Time: Research Grants and Awards: From 6 to
9 months. SBIR and STTR: About 7-1/2 months.
Appeals:
A principal investigator (P.I.) may question the substantive or
procedural aspects of the review of his/her application by communicating
with the staff of the Institute. A description of the NIH Peer
Review Appeal procedures is available on the NIH home page nih.gov/grants/guide/1997/97.11.21/n2.html.
Renewals:
Research Grants and Cooperative Agreements: Subject to same criteria
as new applications. Independent Scientist Awards, Mentored Research
Scientist Development Awards, Mentored Clinical Scientist Development
Award, and the Academic Career Awards are non-renewable.
ASSISTANCE CONSIDERATIONS:
Formula and Matching
Requirements: This program has no statutory
formula or matching requirements.
Length and Time Phasing
of Assistance: Research Grants and Cooperative
Agreements may be awarded for up to 5 years, generally in 12-month
budget periods and may be extended through a competitive renewal.
Funds are released primarily on basis of an Electronic Transfer
System. Science Education Grants may be awarded for up to 3 years,
in 12-month budget periods, and are not renewable. Independent
Scientist Awards are awarded for 5 years in 12-month budget periods,
and are non- renewable. Mentored Research Scientist Awards are
for up to 5 years, 12-month budget periods, and are non-renewable.
Mentored Clinical Scientist Development Awards and Academic Career
Awards are for up to 5 years and are renewable. SBIR: Normally,
Phase I awards are for 6 months; normally, Phase II awards are
for 2 years. STTR: Normally, Phase I awards are for 1 year; normally,
Phase II awards are for 2 years.
POST ASSISTANCE REQUIREMENTS:
Reports:
Research Grants and Awards. Annual and final progress reports and
reports of expenditures are required.
Audits:
In accordance with the provisions of OMB Circular No. A- 133 (Revised,
June 24, 1997), "Audits of States, Local Governments, and Non-Profit
Organizations," nonfederal entities that expend financial assistance
of $300,000 or more in Federal awards will have a single or a
program-specific audit conducted for that year. Nonfederal entities
that expend less than $300,000 a year in Federal awards are exempt
from Federal audit requirements for that year, except as noted
in Circular No. A-133. In addition, grants and cooperative agreements
are subject to inspection and audits by DHHS and other Federal
officials.
Records:
Expenditures and other financial records must be retained for
3 years from the day on which the grantee submits the last financial
status report for the report period.
FINANCIAL INFORMATION:
Account Identification:
75-0862-0-1-552.
Obligations:
(Grants) FY 01 $35,000,000; FY 02 est $39,000,000; and FY 03 est
$43,000,000.
Range
and Average of Financial Assistance:
Research Grants: $57,958 to $1,209,814; Average: $397,727.
SBIR Grants: Phase I - approximately $100,000; Phase II
- up to $750,000. STTR Grants Phase I - $100,000;
Phase II - up to $500,000.
In fiscal year 2001, 88
research grant awards were made of which 33 were competitive RPG
applications. During fiscal year 2002, 114 research grant awards
are expected to be made. In fiscal year 2003, it is anticipated
that 104 research grant awards will be made. In fiscal year 1998,
NIEHS awarded a 5-year $6.3 million grant to the University of Maryland
to investigate the adverse health effects of exposure to the toxin
produced by the microorganism pfiesteria piscicida. Pfiesteria has
recently been associated with extensive summer fish kills along
the eastern seaboard. The health effects of human exposure to the
toxin produced by the bacteria have not been adequately determined.
Commercial fisherman and pleasure boaters are at greatest risk of
exposure when they are in areas where fish kills have occurred.
The grant will fund neurocognitive and neurotoxologic studies and
mechanisms underlying Pfiesteria toxicity and toxin production.
Researchers will also work to develop DNA "fingerprinting" tools
to monitor, identify and classify Pfiesteria species.
REGULATIONS, GUIDELINES, AND
LITERATURE:
42 CFR 52; 45 CFR 74;
45 CFR 92; NIH Guide to Grants and Contracts; various other publications
and application kits, Division of Extramural Outreach and Information
Resources, Office of Extramural Research, NIH, Room 6207, 6701 Rockledge
Drive, Bethesda, MD 20892. SBIR and STTR: Grants will be available
under the authority of and administered in accordance with the PHS
Grants Policy Statement and Federal Regulations at 42 CFR 52 and
42 U.S.C. 241; Omnibus Solicitation of the Public Health Service
for Small Business Innovation Research (SBIR) Grant and Cooperative
Agreement Applications. Omnibus Solicitation of the National Institutes
of Health for Small Business Technology Transfer (STTR) Grant Applications.
INFORMATION CONTACTS:
Regional or Local
Office: Not applicable.
Headquarters Office:
Program Contracts: Research Grants, Dr. William Suk, Director,
Office of Program Development, DERT, NIEHS, E-mail, suk@niehs.nih.gov.
Telephone: (919)541-0797; or Dr. Michael McClure, Chief, Organ
and Systems Toxicology Branch, E-mail: mcclure@niehs.nih.gov.
Telephone: (919)541-5327. Science Education Grants, Dr. Allen
Dearry, Program Administrator, Chemical Exposures and Molecular
Biology Branch, Telephone: (919)541-4943; Cooperative Agreements,
SBIR Grants, Independent Scientist Awards, Mentored Research Scientist
Development Award, Mentored Clinical Research Scientist Development
Award, Academic Career Award and SBIR and STTR Grant Programs:
Dr. Jerrold Heindel, Program Administrator, Organ and Systems
Toxicology Branch, E-mail: heindelj@niehs.nih.gov. Telephone:
(919)541-0781. For each program contact, the rest of the mailing
address is: Division of Extramural Research and Training, National
Institute of Environmental Health Sciences, National Institutes
of Health, P.O. Box 12233, Research Triangle Park, NC 27709. Grants
Management Contact: Ms. Dorothy Duke, Chief, Grants Management
Officer, Grants Management Branch, Division of Extramural Research
and Training, National Institute of Environmental Health Sciences,
National Institutes of Health, P.O. Box 12233, Research Triangle
Park, NC 27709. Telephone: (919)541-2749. E-mail: duke3@niehs.nih.gov.
Web Site Address: http://www.cdc.gov
EXAMPLES OF FUNDED PROJECTS:
The following projects
have been supported: (1) Acid aerosol exposure effects on respiratory
morbidity; and (2) health effects of lead on child development.
CRITERIA FOR SELECTING PROPOSALS:
The major elements in
evaluating proposals include assessments of: (1) The scientific
merit and general significance of the proposed study and its objectives;
(2) the technical adequacy of the experimental design and approach;
(3) the competency of the proposed investigator or group to successfully
pursue the project; (4) the adequacy of the available and proposed
facilities and resources; (5) the necessity of the budget components
requested in relation to the proposed project; and (6) the relevance
and importance to announced program objectives. The following criteria
will be used in considering the scientific and technical merit of
SBIR and STTR Phase I grant applications: (1) The soundness and
technical merit of the proposed approach; (2) the qualifications
of the proposed principal investigator, supporting staff, and consultants;
(3) the technological innovation of the proposed research; (4) the
potential of the proposed research for commercial application; (5)
the appropriateness of the budget requested; (6) the adequacy and
suitability of the facilities and research environment; and (7)
where applicable, the adequacy of assurances detailing the proposed
means for (a) safeguarding human or animal subjects, and/or (b)
protecting against or minimizing any adverse effect on the environment.
Phase II grant applications will be reviewed based upon the following
criteria: (1) The degree to which the Phase I objectives were met
and feasibility demonstrated; (2) the scientific and technical merit
of the proposed approach for achieving Phase II objectives; (3)
the qualifications of the proposed principal investigator, supporting
staff, and consultants; (4) the technological innovation, originality,
or societal importance of the proposed research; (5) the potential
of the proposed research for commercial application; (6) the reasonableness
of the budget requested for the work proposed; (7) the adequacy
and suitability of the facilities and research environment; and
(8) where applicable, the adequacy of assurances detailing the proposed
means for (a) safeguarding human or animal subjects, and/or (b)
protecting against or minimizing any adverse effect on the environment.